Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$175.14

-4.18 (-2.33%)

, AMRX

Amneal Pharmaceuticals

$18.63

0.29 (1.58%)

13:05
07/13/18
07/13
13:05
07/13/18
13:05

Jazz 'confident' in defending Xyrem in District Court, says Wells Fargo

Following news that the U.S. Court of Appeals for the Federal Circuit affirmed a series of rulings in favor of Amneal Pharmaceuticals (AMRX) that patents owned by Jazz Pharmaceuticals (JAZZ) related to its Xyrem drug are invalid, Wells Fargo analyst David Maris tells investors in a research note that he spoke with Jazz this morning and they said they "feel confident" in defending Xyrem in the District Court should the case go to trial. Additionally, Jazz, which said a trial date has not yet been set, said they have now settled with 8 out of 9 of the District Court challenges. Maris believes the reaction today is "overdone," as Jazz still has a strong portfolio to defend Xyrem and the company has shown a clear willingness to settle.

JAZZ

Jazz Pharmaceuticals

$175.14

-4.18 (-2.33%)

AMRX

Amneal Pharmaceuticals

$18.63

0.29 (1.58%)

  • 09

    Aug

  • 27

    Oct

  • 20

    Dec

JAZZ Jazz Pharmaceuticals
$175.14

-4.18 (-2.33%)

07/11/18
07/11/18
DOWNGRADE
Target $183

Equal Weight
Jazz Pharmaceuticals downgraded to Equal Weight after rally at Morgan Stanley
As previously reported, Morgan Stanley analyst David Risinger downgraded Jazz Pharmaceuticals to Equal Weight from Overweight as a rally in the stock has brought it to a closing price on Tuesday of $180.57, which is approaching his unchanged price target of $183. He believes potential M&A could add new growth drivers and diversify Jazz from Xyrem, which is expected to represent about 70% of its FY18 revenue, but Risinger also thinks investors already anticipate action on that front.
07/11/18
07/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing valuation. 2. Jazz Pharmaceuticals (JAZZ) downgraded to Equal Weight at Morgan Stanley with analyst David Risinger saying he believes potential M&A could add new growth drivers and diversify Jazz from Xyrem, which is expected to represent about 70% of its FY18 revenue, but Risinger also thinks investors already anticipate action on that front. 3. U.S. Cellular (USM) and Telephone and Data (TDS) were downgraded to Underweight from Neutral at JPMorgan. 4. Hess Corp. (HES) downgraded to Underweight from Equal Weight at Barclays with analyst Paul Cheng saying his analysis indicates Hess trades at the "steepest premium" in the group. 5. Westlake Chemical (WLK) downgraded to Neutral from Buy at Nomura Instinet with analyst Aleksey Yefremov saying he expects softer demand to weigh on cyclical stocks and reduced his estimates for seven names in the Americas Chemicals space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/18
EVER
07/13/18
NO CHANGE
EVER
Outperform
Jazz Pharmaceuticals patent ruling a 'non-issue, says Evercore ISI
07/13/18
07/13/18
NO CHANGE
Target $160

Outperform
Evercore ISI says appeals court decision on Xyrem patents a 'non-issue' for Jazz
As previously reported, Evercore ISI analyst Umer Raffat called news that an appeals court found that seven Jazz Pharmaceuticals (JAZZ) patents being challenged by Amneal Pharmaceuticals (AMRX) are invalid a "non-issue," stating that his quick read of today's decision shows it all relates to the REMS patents and the core basis for patent life is the valproate patents. He said the patents that were ruled invalid "are not particularly relevant for Xyrem's patent estate" and he does not find today's ruling "of much significance." Raffat keeps an Outperform rating on Jazz shares, which are down 2% to $175.48 in morning trading.
AMRX Amneal Pharmaceuticals
$18.63

0.29 (1.58%)

05/18/18
JPMS
05/18/18
INITIATION
Target $18
JPMS
Neutral
Amneal Pharmaceuticals initiated with a Neutral at JPMorgan
JPMorgan analyst Chris Schott started Amneal Pharmaceuticals with a Neutral rating and $18 price target. The company is well positioned within the generics space, but its valuation trades at a premium to peers, Schott tells investors in a research note. He also notes the company's 2018 guidance requires a "significant step up" in EBITDA from Q1 levels based on a heavy cycle of upcoming pipeline launches.
05/18/18
05/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasterCard (MA) initiated with a Neutral at UBS. 2. AMD (AMD) initiated with an Outperform at Cowen while Intel (INTC) was initiated with a Market Perform. 3. Synthetic Biologics (SYN) initiated with a Buy at H.C. Wainwright. 4. Amneal Pharmaceuticals (AMRX) initiated with a Neutral at JPMorgan. 5. Apollo Commercial (ARI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/18
RILY
06/22/18
INITIATION
Target $26
RILY
Buy
Amneal Pharmaceuticals initiated with a Buy at B. Riley FBR
B. Riley FBR analyst David Buck started Amneal Pharmaceuticals with a Buy rating and $26 price target. The merger of two niche generic companies created a new generic leader, Buck tells investors in a research note.

TODAY'S FREE FLY STORIES

13:50
10/23/18
10/23
13:50
10/23/18
13:50
General news
Fed's Bostic continues to tout a gradual path of tightening »

Fed's Bostic…

UNP

Union Pacific

$143.76

-3.04 (-2.07%)

13:47
10/23/18
10/23
13:47
10/23/18
13:47
Periodicals
Union Pacific eliminating 475 positions by year end, World-Herald says »

Union Pacific said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

LNG

Cheniere Energy

$61.13

-2.36 (-3.72%)

13:45
10/23/18
10/23
13:45
10/23/18
13:45
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

GOOG

Alphabet

$1,095.61

-4.91 (-0.45%)

, GOOGL

Alphabet Class A

$1,104.31

-6.89 (-0.62%)

13:44
10/23/18
10/23
13:44
10/23/18
13:44
Periodicals
Google will fix Pixel photo saving issue with software update, Verge says »

Google will fix a trouble…

GOOG

Alphabet

$1,095.61

-4.91 (-0.45%)

GOOGL

Alphabet Class A

$1,104.31

-6.89 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

RFP

Resolute Forest

$11.70

-0.12 (-1.02%)

13:41
10/23/18
10/23
13:41
10/23/18
13:41
Conference/Events
Resolute Forest to hold a press conference »

Management announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AEP

American Electric

$73.15

0.01 (0.01%)

13:40
10/23/18
10/23
13:40
10/23/18
13:40
Hot Stocks
American Electric increases quarterly dividend 8.1% to 67c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

YEXT

Yext

$18.57

0.18 (0.98%)

, SNAP

Snap

$6.83

-0.01 (-0.15%)

13:39
10/23/18
10/23
13:39
10/23/18
13:39
Hot Stocks
Snapchat joins the Yext knowledge network »

Yext (YEXT) announced a…

YEXT

Yext

$18.57

0.18 (0.98%)

SNAP

Snap

$6.83

-0.01 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

  • 13

    Nov

YEXT

Yext

$18.57

0.18 (0.98%)

13:35
10/23/18
10/23
13:35
10/23/18
13:35
Hot Stocks
Yext announces next generation of DKM, Yext Brain »

Yext announced the next…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

SLG

SL Green Realty

$91.75

-0.04 (-0.04%)

13:35
10/23/18
10/23
13:35
10/23/18
13:35
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$39.46

-0.895 (-2.22%)

13:35
10/23/18
10/23
13:35
10/23/18
13:35
Options
HSBC put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODT

Odonate Therapeutics

$15.48

0.69 (4.67%)

13:33
10/23/18
10/23
13:33
10/23/18
13:33
Recommendations
Odonate Therapeutics analyst commentary  »

Odonate fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URI

United Rentals

$115.41

0.51 (0.44%)

13:25
10/23/18
10/23
13:25
10/23/18
13:25
Options
United Rentals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
10/23/18
10/23
13:25
10/23/18
13:25
Conference/Events
The Brookings Institution to hold a discussion »

Panel discussion on the…

ORCL

Oracle

$47.95

0.02 (0.04%)

13:21
10/23/18
10/23
13:21
10/23/18
13:21
Hot Stocks
Oracle to acquire DataFox, terms not disclosed »

On October 22, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

13:20
10/23/18
10/23
13:20
10/23/18
13:20
General news
Treasury Action: short yields remained subdued »

Treasury Action: short…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/23/18
10/23
13:17
10/23/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/23/18
10/23
13:16
10/23/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$6.82

0.2 (3.02%)

13:15
10/23/18
10/23
13:15
10/23/18
13:15
Options
GoPro put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

13:15
10/23/18
10/23
13:15
10/23/18
13:15
General news
Treasury's $38 B 2-year auction was fairly well received »

Treasury's $38 B…

13:15
10/23/18
10/23
13:15
10/23/18
13:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

13:11
10/23/18
10/23
13:11
10/23/18
13:11
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:10
10/23/18
10/23
13:10
10/23/18
13:10
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

XOM

Exxon Mobil

$79.26

-1.89 (-2.33%)

13:10
10/23/18
10/23
13:10
10/23/18
13:10
Periodicals
Exxon, Rosneft to build LNG plant with Japanese, Indian partners, Reuters says »

According to sources,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$86.62

-2 (-2.26%)

13:07
10/23/18
10/23
13:07
10/23/18
13:07
Hot Stocks
OCC assesses $100M civil money penalty against Capital One »

The Office of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

WFC

Wells Fargo

$51.29

-0.35 (-0.68%)

13:05
10/23/18
10/23
13:05
10/23/18
13:05
Hot Stocks
Wells Fargo to hire new technology head to join Wells Fargo Operating Committee »

Wells Fargo announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.